Showing 131-140 of 8647 results for "".
Aldeyra Resubmits NDA for DED Drug Reproxalap
https://modernod.com/podcasts/eyewire-news-the-podcast/aldeyra-resubmits-nda-for-ded-drug-reproxalap/37053/Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace.Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/water-free-ciclosporin-based-eye-drop-for-ded-approved-in-europe/37052/Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08282024/37047/Rayner Unveils First AI-Designed Spiral IOL • Visionix Launches VX 610 Non-Mydriatic Automated Fundus Camera • Injectsense Completes First Human Implant of Ultraminiature IOP SensorWe Await the Fate of a New Presbyopia Drop
https://modernod.com/articles/significant-findings/we-await-the-fate-of-a-new-presbyopia-drop/37799/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatStudy Highlights Safety of OD-Performed Laser Procedures
https://modernod.com/articles/significant-findings/study-highlights-safety-of-od-performed-laser-procedures/37797/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatSleep Apnea and NPDR
https://modernod.com/articles/significant-findings/sleep-apnea-and-npdr/37796/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatHave an Astronaut for a Patient?
https://modernod.com/articles/significant-findings/have-an-astronaut-for-a-patient/37792/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDealing With Peer-to-Peer Authorizations
https://modernod.com/articles/significant-findings/dealing-with-peer-to-peer-authorizations/37791/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatKeep Cataracts at Bay With Physical Activity
https://modernod.com/articles/significant-findings/keep-cataracts-at-bay-with-physical-activity/37789/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatWe’re Still Learning About COVID-19
https://modernod.com/articles/significant-findings/were-still-learning-about-covid-19/37786/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat
